Stanhope Plc has completed the purchase of Building 7, Chiswick Park

Stanhope Plc has completed the purchase of Building 7, Chiswick Park from funds managed by Blackstone. The purchase price was around £310m.
Stanhope bought the 335,000 sq ft Grade A office building with the backing of existing private clients. The asset is 95% let to blue chip covenants including Pernod Ricard, Starbucks and British American Tobacco.
The seller was advised by Knight Frank and JLL.
Stanhope was the original developer of Chiswick Park which was the first office development in London to embrace the idea that people are more important than bricks and mortar. Stretching over 12 buildings in a 33 acre site, situated around a central pedestrian space made up of a lake, landscaping and open-air performance area, the development established a people-centric destination where individuals and businesses could exchange ideas and embrace new ways of working.
Chiswick Park has enjoyed numerous awards and been widely recognised for its role in establishing a new standard for workplaces in the UK and beyond.
Related

Stanhope’s Kett House office scheme in Cambridge secures resolution to grant planning
Stanhope and Bennetts Associates have secured a resolution to grant planning permission from Cambridge City Council for the renewal of Kett House in Cambridge.

Stanhope and Allies and Morrison to lead masterplan for redevelopment of St Mary’s Hospital, including expansion of surrounding life sciences cluster
Landmark NHS project to build on hospital’s long track record in excellence in healthcare and innovation, creating economic growth and job opportunities as well as better health outcomes

First letting secured at £1.2 billion Oxford North global innovation district
International law firm Mishcon de Reya’s Thames Valley Team taking 3,500 sq ft of recently opened first phase.

Lord Hague of Richmond officially opens Oxford North
Lord Hague of Richmond officially opens £1.2 billion Oxford North flagship global innovation district in major boost to UK science, technology & AI sectors